TickerFactsScreenerDevelopers

Adaptive Biotechnologies Corp (ADPT) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2018: $55.03M2019: $96.58M2020: $123.44M2021: $139.06M2022: $90.03M2023: $65.06M2024: $47.92M2025: $70.50M$70.50M
2018Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$70.50M+47.1%
2024$47.92M-26.3%
2023$65.06M-27.7%
2022$90.03M-35.3%
2021$139.06M+12.7%
2020$123.44M+27.8%
2019$96.58M+75.5%
2018$55.03M—